Correspondence 0001193125-23-099209 from CalciMedica, Inc. (CALC)
CalciMedica, Inc.
Date: April 12, 2023 · CIK: 0001534133 · Accession: 0001193125-23-099209
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-271115
Letter
CALCIMEDICA, INC.
505 Coast Boulevard South, Suite 307
La Jolla, CA 92037
April 12, 2023
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Ms. Cindy Polynice
RE: CalciMedica, Inc.
Registration Statement on Form S-3
File No. 333-271115
Ladies and Gentlemen:
CalciMedica, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on April 14, 2023, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Carlos Ramirez of Cooley LLP and Christine Turner of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Carlos Ramirez at (858) 550-6157, or in his absence, Christine Turner of Cooley LLP at (720) 566-4163.
Very truly yours,
CALCIMEDICA, INC.
Show Raw Text
CORRESP 1 filename1.htm CORRESP CALCIMEDICA, INC. 505 Coast Boulevard South, Suite 307 La Jolla, CA 92037 April 12, 2023 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attn: Ms. Cindy Polynice RE: CalciMedica, Inc. Registration Statement on Form S-3 File No. 333-271115 Ladies and Gentlemen: CalciMedica, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective on April 14, 2023, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes Carlos Ramirez of Cooley LLP and Christine Turner of Cooley LLP, counsel to the Registrant, to make such request on its behalf. Once the Registration Statement has been declared effective, please orally confirm that event with Carlos Ramirez at (858) 550-6157, or in his absence, Christine Turner of Cooley LLP at (720) 566-4163. Very truly yours, CALCIMEDICA, INC. By: /s/ A. Rachel Leheny, Ph.D. Name: A. Rachel Leheny, Ph.D. Title: Chief Executive Officer cc: John Dunn, CalciMedica, Inc. Carlos Ramirez, Cooley LLP Christine Turner, Cooley LLP